SCIENTURE HOLDINGS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
SCIENTURE HOLDINGS, INC. (SCNX) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$9.07 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$9.07M.
- SCIENTURE HOLDINGS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$2.02M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | -$9.07M 10-K · filed 2026-03-30 |
| 2024-12-31 | -$2.02M 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |